Diagnostic Performance of a Novel Ferumoxytol-Enhanced Magnetic Resonance Angiography/ Venography on Panvascular Disease | MicrobiomeTrials← Back to trialsNCT06136806
Diagnostic Performance of a Novel Ferumoxytol-Enhanced Magnetic Resonance Angiography/ Venography on Panvascular Disease
UNKNOWNOBSERVATIONAL
Trial Details
Start: 2024-02-23Est. Completion: 2025-01-30
Enrollment target: 200 participants Locations- First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Other microbiome trials you might be interested in
Cohort StudyNatural PopulationNorthwest Region of China
This population-based cohort study on disease prevention and health promotion was established in northwest China, levera…
Ürümqi, ChinaEst. completion Dec 31, 2035
Panvascular DiseasesCardiovascular Diseases
This study aims to establish a standardized cohort for panvascular diseases, encompassing biological materials such as D…
Harbin, ChinaEst. completion Dec 31, 2030